Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
Multiple myeloma (MM) remains an incurable tumor due to the high rate of relapse that still occurs. Acquired drug resistance represents the most challenging obstacle to the extension of survival and several studies have been conducted to understand the mechanisms of this phenomenon. Mitochondrial pa...
Main Authors: | Vanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, Caterina Musolino, Alessandro Allegra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/2/439 |
Similar Items
-
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient
by: Vanessa Innao, et al.
Published: (2017-05-01) -
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
by: Vanessa Innao, et al.
Published: (2020-12-01) -
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
by: Andrea Gaetano Allegra, et al.
Published: (2020-11-01) -
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01) -
Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
by: Giuseppe Murdaca, et al.
Published: (2021-08-01)